Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.
- Market Cap ₹ 3,732 Cr.
- Current Price ₹ 300
- High / Low ₹ 809 / 277
- Stock P/E 17.4
- Book Value ₹ 41.6
- Dividend Yield 1.50 %
- ROCE 64.4 %
- ROE 61.3 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
- Debtor days have improved from 49.0 to 31.8 days.
- Company's working capital requirements have reduced from 21.2 days to 14.6 days
Cons
- Stock is trading at 7.21 times its book value
- Promoter holding has decreased over last 3 years: -4.24%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
(S): Standalone figures, shown where consolidated figures are not available.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 106 | 94 | 136 | 147 | 205 | 469 | 801 | 897 | |
| Sales growth | -11% | +44% | +40% | +71% | +45% | |||
| 95 | 84 | 119 | 128 | 159 | 328 | 451 | 554 | |
| Operating Profit | 11 | 11 | 17 | 18 | 46 | 141 | 351 | 343 |
| OPM % | 10% | 11% | 13% | 12% | 22% | 30% | 44% | 38% |
| 0 | 1 | 1 | 1 | 3 | 7 | 8 | 18 | |
| Interest | 1 | 2 | 1 | 1 | 1 | 11 | 14 | 14 |
| Depreciation | 1 | 2 | 2 | 3 | 3 | 29 | 48 | 60 |
| Profit before tax | 8 | 8 | 14 | 15 | 44 | 108 | 297 | 287 |
| Tax % | 28% | 26% | 27% | 26% | 24% | 26% | 25% | |
| 6 | 6 | 10 | 11 | 34 | 80 | 222 | 214 | |
| EPS in Rs | 0.66 | 0.63 | 1.13 | 1.23 | 2.72 | 6.43 | 17.84 | 17.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 8% | 17% | 25% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 58% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 88% |
| TTM: | 44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 31% |
| 1 Year: | -57% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 61% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.10 | 10 | 14 | 25 | 25 | 25 |
| Reserves | 8 | 14 | 24 | 26 | 112 | 231 | 442 | 492 |
| 16 | 12 | 12 | 7 | 1 | 117 | 127 | 168 | |
| 12 | 12 | 13 | 18 | 24 | 46 | 80 | 141 | |
| Total Liabilities | 36 | 38 | 49 | 62 | 151 | 419 | 674 | 827 |
| 13 | 17 | 23 | 29 | 60 | 253 | 293 | 304 | |
| CWIP | 0 | 0 | 0 | 5 | 1 | 13 | 3 | 1 |
| Investments | 0 | 0 | 0 | 0 | 5 | 4 | 110 | 124 |
| 23 | 21 | 26 | 28 | 86 | 149 | 269 | 397 | |
| Total Assets | 36 | 38 | 49 | 62 | 151 | 419 | 674 | 827 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 1 | 12 | 18 | 16 | 15 | 84 | 254 | |
| -11 | -6 | -8 | -18 | -33 | -64 | -202 | |
| 7 | -5 | -2 | -5 | 48 | -22 | -59 | |
| Net Cash Flow | -2 | 1 | 8 | -7 | 29 | -2 | -7 |
| Free Cash Flow | -10 | 6 | 9 | -2 | -15 | 45 | 221 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 35% | 130% | 125% | 112% | 50% | 84% | 93% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 | Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 17 | 9 | 23 | 39 | 66 | 32 |
| Inventory Days | 204 | 315 | 208 | 149 | 85 | 78 | 81 |
| Days Payable | 125 | 168 | 73 | 109 | 126 | 106 | 92 |
| Cash Conversion Cycle | 94 | 163 | 143 | 62 | -1 | 38 | 20 |
| Working Capital Days | -16 | -15 | -19 | -12 | 28 | 28 | 15 |
| ROCE % | 38% | 50% | 52% | 64% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Active Operational Centres centres |
|
|||||
| IPD Patient Volumes patients |
||||||
| Medicine Order Volumes lakh orders |
||||||
| OPD Patient Volumes lakh patients |
||||||
| Beds Occupied beds |
||||||
| Operational Beds beds |
||||||
| SKUs in Portfolio SKUs |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Submitted Q2 FY27 earnings call transcript; revenue ₹235 Cr, EBITDA ₹72 Cr, PAT ₹36 Cr.
-
Disclosure Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') - Commencement Of Operations At Client Support Centre Facility At Noida, Uttar Pradesh.
- Jeena Sikho commenced operations at its 17,700 sq. ft. client support centre in Noida on November 18, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of Q2 FY 2026-27 earnings conference call made available on company website.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement under Regulation 30 (LODR)-Investor Presentation
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from nse
-
Annual Report 2023
from nse
-
Annual Report 2022
from nse
Concalls
-
Nov 2026Transcript PPT REC
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT REC
-
May 2026PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Aug 2025PPT
-
Jul 2025REC
-
May 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Nov 2024PPT REC
-
May 2024Transcript PPT
-
Feb 2024PPT
-
Aug 2023PPT
-
Aug 2023PPT
Business Segment:[1][2]
a) Hospitals & Clinics Portfolio
Jeena Sikho Lifecare Limited (JSLL) operates a network of 119 active centers (61 hospitals + 58 clinics/day-care centres), across 23 states and 100+ cities/towns. The hospitals have 2300 operational beds, with another 445 beds in the pipeline. 561 beds were added in FY26. ompany has ~592 certified Ayurveda doctors and ~780 supporting healthcare personnel.